DaVita Inc. (DVA) Insider Trading Activity

NYSE$199.74
Market Cap
$12.82B
Sector
Healthcare
Industry
Medical—Care Facilities
Rank in Sector
548 of 874
Rank in Industry
26 of 39

DVA Insider Trading Activity

DVA Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$699,770,280
11
100

Related Transactions

HEARTY JAMES OChief Compliance Officer
0
$0
2
$734,566
$-734,566
Maughan David PaulChief Operating Officer, DKC
0
$0
2
$4.09M
$-4.09M
BERKSHIRE HATHAWAY INC10 percent owner
0
$0
7
$694.95M
$-694.95M

About DaVita Inc.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Insider Activity of DaVita Inc.

Over the last 12 months, insiders at DaVita Inc. have bought $0 and sold $699.77M worth of DaVita Inc. stock.

On average, over the past 5 years, insiders at DaVita Inc. have bought $1.91M and sold $216.03M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 5,000 shares for transaction amount of $355,675 was made by NEHRA JOHN M (director) on 2022‑11‑01.

List of Insider Buy and Sell Transactions, DaVita Inc.

Total: 0

Insider Historical Profitability

9.38%

DVA Institutional Investors: Active Positions

Increased Positions264+37.71%6M+8.42%
Decreased Positions315-45%6M-9.34%
New Positions79New859,071New
Sold Out Positions102Sold Out1MSold Out
Total Postitions649-7.29%67M-0.92%

DVA Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Berkshire Hathaway Inc$3.68M45.3%32.16M-2M-4.84%2025-09-30
Vanguard Group Inc$484,137.005.96%4.23M-519,622-10.95%2025-09-30
Blackrock, Inc.$409,489.005.04%3.58M-537,342-13.06%2025-09-30
State Street Corp$210,106.002.58%1.83M-258,505-12.35%2025-09-30
Invesco Ltd.$192,291.002.37%1.68M+32,358+1.97%2025-09-30
Morgan Stanley$160,988.001.98%1.41M-143,760-9.28%2025-09-30
Gates Capital Management, Inc.$136,311.001.68%1.19M+91,403+8.32%2025-09-30
Dimensional Fund Advisors Lp$124,311.001.53%1.09M+88,061+8.83%2025-09-30
Geode Capital Management, Llc$117,187.001.44%1.02M-86,311-7.78%2025-09-30
Lsv Asset Management$106,154.001.31%927,029-13,700-1.46%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.